Defending his decision to go ahead with a U.S. Senate Health, Education, Labor and Pensions (HELP) Committee hearing Tuesday on the next renditions of the FDA drug and device user fee agreements, Sen. Lamar Alexander (R-Tenn.) stressed the importance of getting the agreements signed into law quickly.